Michael Patrick Miller's Net Worth

$8.44 Million

Estimate Recalculated May 8, 2026 01:19PM EST

Who is Michael Patrick Miller

Michael Patrick Miller has an estimated net worth of $8.44 Million. This is based on reported shares across multiple companies, which include Jazz Pharmaceuticals plc, PUMA BIOTECHNOLOGY, INC., BioXcel Therapeutics, Inc., VIVUS INC, and CONNETICS CORP.

SEC CIK

Michael Patrick Miller's CIK is 0001236514

Past Insider Trading and Trends

2005 was Michael Patrick Miller's most active year for acquiring shares with 12 total transactions. Michael Patrick Miller's most active month to acquire stocks was the month of May. 2005 was Michael Patrick Miller's most active year for disposing of shares, totalling 21 transactions. Michael Patrick Miller's most active month to dispose stocks was the month of May. 2005 saw Michael Patrick Miller paying a total of $1,703,250.00 for 95,000 shares, this is the most they've acquired in one year. In 2012 Michael Patrick Miller cashed out on 150,000 shares for a total of $2,085,900.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Jazz Pharmaceuticals plc

EVP, US Commercial
Updated Mar 13, 2020
ScheduledMar 12
Mar 05
Feb 25
ScheduledFeb 13
ScheduledJan 13
ScheduledDec 09
Jun 05
Mar 05
53.50KFeb 28
Feb 25 - Feb 26
ScheduledNov 13
ScheduledOct 12
ScheduledSep 14
ScheduledAug 14
ScheduledJul 13
ScheduledJun 14
Jun 05
ScheduledMay 14
May 07
ScheduledApr 13
ScheduledMar 14
Mar 05
48.53KMar 01
Feb 26
ScheduledFeb 14
ScheduledJan 12
ScheduledDec 11
ScheduledAug 15
ScheduledJul 17
ScheduledJun 15
ScheduledMay 11 - May 15
May 05
ScheduledApr 17
ScheduledMar 15
41.71KMar 02
Feb 27
ScheduledFeb 15
ScheduledJan 17
ScheduledDec 15
ScheduledNov 15
ScheduledOct 17
ScheduledSep 19
ScheduledAug 15
ScheduledJul 15
ScheduledJun 15
ScheduledMay 16
May 05
ScheduledApr 15
ScheduledMar 15
Feb 25 - Feb 26
ScheduledFeb 16
ScheduledJan 15
ScheduledDec 15
ScheduledNov 16
ScheduledOct 15
ScheduledSep 25
May 05
27.36KFeb 26
10.00K
Showing 59 results

PUMA BIOTECHNOLOGY, INC.

Investor
Updated Aug 13, 2024
Aug 12
95.36KJun 18
Nov 07
Jun 13
Aug 09
79.86KJun 14
Mar 16
78.51KJun 15
50.65KJun 09
24.91KJun 10
5.48KJun 12
17.63KFeb 23
Showing 13 results

BioXcel Therapeutics, Inc.

Investor
Updated Jun 11, 2024
17.00KJun 10
17.00KJun 26
30.00KJul 01
Showing 4 results

VIVUS INC

Chief Commercial Officer
Updated Jan 29, 2013
98.06KJan 25
ScheduledJul 18
ScheduledJun 27
ScheduledJun 12
95.76KJan 27
54.40KJan 21
400.00KApr 30
Showing 8 results

CONNETICS CORP

SVP Sales & Marketing & CCO
Updated Nov 02, 2005
ScheduledNov 01
ScheduledOct 03
ScheduledSep 01
ScheduledAug 01
ScheduledJul 01
ScheduledMay 31 - Jun 01
ScheduledMay 02
ScheduledApr 01
ScheduledMar 01
ScheduledFeb 01
591.39KJan 18
ScheduledNov 30 - Dec 01
ScheduledNov 01
ScheduledOct 01
ScheduledSep 01
ScheduledAug 02
ScheduledJul 01
ScheduledMay 28 - Jun 01
ScheduledMay 03
ScheduledApr 01
Nov 28
Showing 21 results